Akshay Churi has been appointed Vice President – Manufacturing at ErlySign (CURO Biosciences Private Limited), where he will lead manufacturing strategy and operational scale-up for the company’s innovative diagnostic solutions.

With more than two decades of experience across medical technology, biosciences, and precision manufacturing, Akshay brings deep expertise in building scalable production systems and high-performance operational teams. In his new role, he will focus on strengthening manufacturing readiness, expanding production capabilities, and supporting the commercialization of ErlySign’s breakthrough cancer detection technologies.

Before joining ErlySign, he held leadership roles at Husky Technologies and ZAHORANSKY, where he gained extensive experience in advanced manufacturing systems, operational excellence, and process optimization within high-precision industries.

ErlySign is working to develop India’s first salivary biomarker–based screening test for early cancer detection, aimed at enabling accessible, non-invasive, and scalable diagnostic solutions. Akshay’s leadership is expected to play a key role in building robust manufacturing infrastructure and supporting the company’s broader vision of expanding access to early cancer detection technologies.